# PAXLOVID (COPACKAGED)
> **NDA217188** · New Drug Application · Sponsor: PFIZER · Approved 2023-05-25
## Drug
- **FDA Application Number:** NDA217188
- **Application type:** New Drug Application
- **Brand name:** PAXLOVID (COPACKAGED)
- **Generic name:** NIRMATRELVIR AND RITONAVIR
- **Active ingredients:** NIRMATRELVIR; RITONAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PFIZER
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2023-05-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217188)
---
*AI Analytics · CC0 1.0*